Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy
Metabolic dysfunction-associated steatohepatitis (MASH) is one of the most common chronic liver diseases, primarily caused by metabolic disorders and systemic inflammatory responses. Although the incidence of MASH is gradually ...
8 hours ago
0
0